A61P 27/14
Decongestants or antiallergics
A61P27/14 (Decongestants or antiallergics) appears on 1,642 US grants and 2,260 published applications in this corpus.
Search patents in A61P- Granted patents
- 1,642
- Published applications
- 2,260
- Assignees
- 837
- Inventors
- 4,452
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 2 | 0 |
| 1988 | 7 | 0 |
| 1989 | 2 | 0 |
| 1990 | 14 | 0 |
| 1991 | 8 | 0 |
| 1992 | 5 | 0 |
| 1993 | 10 | 0 |
| 1994 | 11 | 0 |
| 1995 | 10 | 0 |
| 1996 | 10 | 0 |
| 1997 | 20 | 0 |
| 1998 | 18 | 0 |
| 1999 | 27 | 0 |
| 2000 | 29 | 0 |
| 2001 | 23 | 9 |
| 2002 | 47 | 56 |
| 2003 | 33 | 71 |
| 2004 | 23 | 104 |
| 2005 | 28 | 108 |
| 2006 | 50 | 113 |
| 2007 | 38 | 125 |
| 2008 | 45 | 125 |
| 2009 | 68 | 153 |
| 2010 | 89 | 201 |
| 2011 | 80 | 133 |
| 2012 | 128 | 170 |
| 2013 | 153 | 153 |
| 2014 | 115 | 139 |
| 2015 | 101 | 98 |
| 2016 | 76 | 97 |
| 2017 | 84 | 85 |
| 2018 | 63 | 80 |
| 2019 | 55 | 51 |
| 2020 | 52 | 41 |
| 2021 | 34 | 44 |
| 2022 | 20 | 25 |
| 2023 | 22 | 30 |
| 2024 | 18 | 20 |
| 2025 | 8 | 14 |
| 2026 | 6 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Rock inhibitors and uses thereof28 Jul 2026US 12,692,234 B2Alcon Inc.
- 1H-pyrazole derivative and application thereof as dual target inhibitor of Syk and VEGFR226 May 2026US 12,637,469 B2Ocumension Therapeutics (Suzhou) Co., Ltd.
- Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies12 May 2026US 12,624,115 B2Regeneron Pharmaceuticals, Inc.
- Composition for use in treatment of allergic diseases5 May 2026US 12,617,837 B2University of Tsukuba
- Pharmaceutical composition containing SIRT7 inhibitor for preventing or treating allergic diseases17 Feb 2026US 12,553,049 B2Korea University Research and Business Foundation
- Rock inhibitors and uses thereof1 Oct 2026US 2026/0297033 A1Alcon Inc.
- Low viscosity pharmaceutical compositions containing mycophenolic acid for the treatment of ocular disorders27 Aug 2026US 2026/0248758 A1Surface Ophthalmics, Inc.
- Nitrogen-containing spiro cyclic compounds and pharmaceutical use thereof20 Aug 2026US 2026/0242385 A1
- Dendrimer-bioadhesive polymer hydrogel nanoglue and use thereof13 Aug 2026US 2026/0232865 A1The Johns Hopkins University
- Lactiplantibacillus plantarum strain, culture medium derived therefrom, and antiallergic uses thereof6 Aug 2026US 2026/0224646 A1Gi Biome
Most cited
By later US patents
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Antibody compositions for selectively inhibiting VEGF356US 6,342,219 B12002
- Methods and compositions for inhibition of angiogenesis231US 5,712,291 AChildren's Medical Center Corporation · 1998
- Substituted biphenyl isoxazole sulfonamides222US 5,612,359 ABristol-Myers Squibb Company · 1997
- Oleaginous pharmaceutical and cosmetic foam202US 7,820,145 B2Foamix Ltd. · 2010